Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Eleni Triantafyllidi"'
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 2045 (2022)
Trastuzumab is a monoclonal antibody used in the treatment of breast cancer in cases where the tumor overexpresses the HER2 receptor, a cell membrane receptor activated by the epidermal growth factor. Intravenous and subcutaneous administration of tr
Externí odkaz:
https://doaj.org/article/089758d5c8bd4ae39854260bf58bbcdf
Autor:
John K. Triantafillidis, Eleni Triantafyllidi, Michail Sideris, Theodoros Pittaras, Apostolos E. Papalois
Publikováno v:
Nutrients, Vol 14, Iss 3, p 619 (2022)
Background: Pancreatic cancer represents the most lethal malignancy among all digestive cancers. Despite the therapeutic advances achieved during recent years, the prognosis of this neoplasm remains disappointing. An enormous amount of experimental (
Externí odkaz:
https://doaj.org/article/cdbebedc617c4b49a8fd1ddd50d3dc47
Autor:
Dimitrios Kouroupis, Athena Kyrkou, Eleni Triantafyllidi, Michalis Katsimpoulas, George Chalepakis, Anna Goussia, Anastasios Georgoulis, Carol Murphy, Theodore Fotsis
Publikováno v:
Stem Cell Research, Vol 17, Iss 2, Pp 448-457 (2016)
In the present study, we combined stem cell technology with a non-absorbable biomaterial for the reconstruction of the ruptured ACL. Towards this purpose, multipotential stromal cells derived either from subcutaneous human adipose tissue (hAT-MSCs) o
Externí odkaz:
https://doaj.org/article/a7b296ca3e3640e6a668d08d16d558eb
Publikováno v:
Nutrients, Vol 12, Iss 4, p 1048 (2020)
Enteral nutrition seems to play a significant role in the treatment of both adults and children with active Crohn’s disease, and to a lesser degree in the treatment of patients with active ulcerative colitis. The inclusion of some special factors i
Externí odkaz:
https://doaj.org/article/fdb5634437df421ba5af74f6b4b0cb18
Publikováno v:
SSRN Electronic Journal.
Autor:
John K. Triantafillidis, Eleni Triantafyllidi, Michail Sideris, Theodoros Pittaras, Apostolos E. Papalois
Publikováno v:
Nutrients, Vol 14, Iss 619, p 619 (2022)
Background: Pancreatic cancer represents the most lethal malignancy among all digestive cancers. Despite the therapeutic advances achieved during recent years, the prognosis of this neoplasm remains disappointing. An enormous amount of experimental (
Publikováno v:
Nutrients, Vol 12, Iss 1048, p 1048 (2020)
Nutrients
Nutrients
Enteral nutrition seems to play a significant role in the treatment of both adults and children with active Crohn’s disease, and to a lesser degree in the treatment of patients with active ulcerative colitis. The inclusion of some special factors i
Publikováno v:
Archives of Clinical and Medical Case Reports.
We describe a rare case of a young patient with Crohn’s disease, who accidentally was found to have developed renal cell carcinoma while on treatment with anti-TNF-α biologic agent. The patient was submitted to laparoscopic resection of the tumor.
Autor:
Michail Sideris, Dimosthenis Chrysikos, Theodoros Pittaras, Alexandros Nomikos, Apostolos Papalois, Maria Korontzi, John K Triantafillidis, Eleni Triantafyllidi, Calypso Barbatis
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2019 (2019)
BioMed Research International, Vol 2019 (2019)
Background/Aim. Treatment with growth factors could be beneficial in both inflammatory bowel disease and experimental colitis. The aim of this study was to investigate the effect of Colony Stimulating Factor (CSF), and Recombinant Human (rHu) Granulo
Autor:
George S. Stergiou, Martino F. Pengo, Alessandro Moloberti, Gianfranco Parati, Aandrzei Januszewicz, Eleni Triantafyllidi, Athanase D. Protogerou, Cristina Giannattasio, Reinhold Kreutz, Jorge Polónia, Enrico Agabiti-Rosei, Michael Doumas, Pantelis Sarafidis, Ioannis Papadakis, Dimitrios Papadopoulos, Eleni Manta, Areti Triantafyllou, Kostas Tsioufis, Giuseppe Mancia, Maria E. Marketou, Rigas Kalaitzidis, Bojan Jelaković, Emmanouil Kallistratos, Vesna Stojanov
Publikováno v:
Journal of Hypertension. 39:e244